We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Baxter International Inc (BAX) Common Stock

Sell:$35.32 Buy:$35.33 Change: $0.1 (0.28%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Change: $0.1 (0.28%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
Change: $0.1 (0.28%)
Market closed |  Prices as at close on 12 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.

Contact details

1 Baxter Parkway,
United States
+1 (847) 9482000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$17.45 billion
Shares in issue:
509.58 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Jose Almeida
    Chairman of the Board, President, Chief Executive Officer
  • Joel Grade
    Chief Financial Officer, Executive Vice President
  • Jeanne Mason
    Chief Human Resource Officer, Executive Vice President
  • David Rosenbloom
    Executive Vice President, General Counsel
  • James Borzi
    Executive Vice President and Chief Supply Chain Officer
  • Heather Knight
    Executive Vice President, Group President - Medical Products and Therapies
  • Reaz Rasul
    Executive Vice President, Group President - Healthcare Systems and Technologies
  • Alok Sonig
    Executive Vice President, Group President - Pharmaceuticals
  • Christopher Toth
    Executive Vice President and Group President, Kidney Care
  • Brian Stevens
    Senior Vice President, Chief Accounting Officer, Controller

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.